Profile
Thiyagaraja Ravindran is currently a Director at UCB Fipar SA since 2018.
Prior to this, he worked as a Director at Zogenix, Inc.
Thiyagaraja Ravindran active positions
| Companies | Position | Start |
|---|---|---|
UCB Fipar SA
 UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Director/Board Member | 08/02/2018 |
Former positions of Thiyagaraja Ravindran
| Companies | Position | End |
|---|---|---|
| ZOGENIX, INC. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
UCB Fipar SA
UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Finance |
- Stock Market
- Insiders
- Thiyagaraja Ravindran